Khiron Life Sciences President Discusses Monumental Colombian Sales Milestone and More

Capital 10X interviewed Khiron Life Sciences President Chris Naprawa to learn more about the company’s inaugural medical cannabis sales in Colombia, a first for any company.

Naprawa also details how Khiron’s operations are well-positioned to weather COVID-19, their plans to dominate all of Latin America, and how a healthy balance sheet and patient-first approach will help them reach their 2020 milestones.

0 0 vote
Article Rating

The opinions provided in this article are those of the author and do not constitute investment advice. Readers should assume that the author and/or employees of Capital 10X hold positions in the company or companies mentioned in the article. For more information, please see our Content Disclaimer.

Evan Veryard
Evan Veryard has a Bachelor's of Chemical Engineering from McGill University and a MaSc. of Chemical Engineering from RMC. He has over 6 years of research experience focusing on industrial materials. Address: 682 Indian Road, Toronto, Ontario, M6P 2C9. Phone: 416-721-8257.
Notify of
Inline Feedbacks
View all comments